Your browser is no longer supported. Please, upgrade your browser.
Settings
EARS Auris Medical Holding Ltd. daily Stock Chart
EARS [NASD]
Auris Medical Holding Ltd.
Index- P/E- EPS (ttm)-2.51 Insider Own8.70% Shs Outstand4.76M Perf Week15.14%
Market Cap4.84M Forward P/E- EPS next Y-4.27 Insider Trans0.00% Shs Float4.12M Perf Month18.49%
Income-7.30M PEG- EPS next Q- Inst Own4.50% Short Float0.82% Perf Quarter9.28%
Sales- P/S- EPS this Y84.20% Inst Trans34.76% Short Ratio0.13 Perf Half Y-23.13%
Book/sh2.28 P/B0.47 EPS next Y-57.00% ROA-68.20% Target Price- Perf Year-59.01%
Cash/sh0.33 P/C3.23 EPS next 5Y- ROE-148.20% 52W Range0.65 - 3.20 Perf YTD-33.33%
Dividend- P/FCF- EPS past 5Y55.50% ROI- 52W High-65.62% Beta0.53
Dividend %- Quick Ratio1.00 Sales past 5Y- Gross Margin- 52W Low69.23% ATR0.10
Employees12 Current Ratio1.00 Sales Q/Q- Oper. Margin- RSI (14)58.09 Volatility11.71% 10.44%
OptionableNo Debt/Eq0.00 EPS Q/Q77.40% Profit Margin- Rel Volume1.92 Prev Close1.08
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume257.54K Price1.10
Recom- SMA2012.35% SMA5013.56% SMA200-6.55% Volume42,786 Change1.85%
Oct-08-18Initiated Euro Pacific Capital Buy $2.50
Apr-13-17Initiated ROTH Capital Buy $4.50
Aug-19-16Reiterated Needham Buy $11 → $5
Sep-09-14Initiated Needham Buy $11
Jul-29-20 08:30AM  
May-26-20 08:30AM  
May-10-20 10:39AM  
Apr-16-20 07:00AM  
Apr-03-20 05:00PM  
Mar-26-20 06:00AM  
Mar-19-20 06:00AM  
Mar-05-20 08:30AM  
Feb-25-20 08:30AM  
Feb-10-20 10:01AM  
Jan-10-20 08:30AM  
Dec-30-19 08:30AM  
Nov-11-19 10:05AM  
Oct-11-19 08:30AM  
Sep-13-19 09:00AM  
Sep-11-19 09:00AM  
Sep-04-19 07:00AM  
Aug-26-19 09:00AM  
Aug-23-19 10:21AM  
Aug-22-19 10:06AM  
Aug-15-19 07:00AM  
Jul-30-19 08:30AM  
Jul-03-19 09:00AM  
Jun-13-19 09:50AM  
May-23-19 09:00AM  
May-20-19 08:45AM  
May-17-19 04:55PM  
May-15-19 04:15PM  
09:00AM  
May-13-19 08:30AM  
May-07-19 09:00AM  
Apr-30-19 08:30AM  
Apr-25-19 09:00AM  
Apr-18-19 12:11PM  
Apr-15-19 09:00AM  
Mar-29-19 09:01AM  
Mar-14-19 09:48PM  
02:30PM  
07:58AM  
07:00AM  
Mar-11-19 08:51AM  
Mar-07-19 08:01AM  
Feb-13-19 10:42AM  
Feb-08-19 05:00PM  
Feb-01-19 07:31AM  
Jan-29-19 07:31AM  
Jan-23-19 09:45AM  
08:31AM  
Jan-15-19 08:31AM  
Dec-06-18 09:15AM  
07:31AM  
Nov-26-18 09:00AM  
Nov-23-18 07:40AM  
Nov-21-18 07:00AM  
Nov-20-18 09:20AM  
Nov-15-18 07:22AM  
06:45AM  
Nov-08-18 07:00AM  
Nov-02-18 08:00AM  
Nov-01-18 12:00PM  
Oct-17-18 06:45AM  
Oct-16-18 08:00AM  
Oct-15-18 04:32PM  
Oct-12-18 07:30AM  
Oct-09-18 08:10AM  
08:00AM  
Aug-30-18 08:16AM  
Aug-15-18 06:59AM  
06:45AM  
Aug-09-18 08:01AM  
Jul-13-18 07:40AM  
Jul-12-18 08:00PM  
Jul-03-18 08:01AM  
Jun-13-18 07:05AM  
Jun-04-18 12:34PM  
May-30-18 07:45AM  
May-22-18 10:13PM  
May-15-18 06:56AM  
06:45AM  
May-14-18 07:30AM  
May-08-18 07:30AM  
May-07-18 09:05AM  
07:30AM  
May-04-18 06:45AM  
Apr-09-18 06:45AM  
Apr-02-18 07:30AM  
Mar-29-18 07:01AM  
Mar-22-18 09:56AM  
09:05AM  
Mar-14-18 08:53AM  
Mar-13-18 04:15PM  
Feb-27-18 06:15PM  
Feb-26-18 08:31AM  
Feb-09-18 08:00AM  
Feb-07-18 09:11AM  
Jan-29-18 04:31PM  
Jan-04-18 08:30AM  
Dec-28-17 08:30AM  
Dec-08-17 03:33PM  
Nov-29-17 08:58PM  
Auris Medical Holding Ltd., a development-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment and prevention of peripheral and central nervous disorders. The company's Phase 3 programs under the development include Keyzilen (AM-101) for the treatment of acute inner ear tinnitus; and Sonsuvi (AM-111) for the treatment of acute inner ear hearing loss. It is also developing AM-125 that is in Phase 2 clinical trial for the intranasal treatment of acute peripheral vertigo; and AM-201, which is in Phase 1b clinical trial for the prevention of weight gain and drowsiness, which are side effects of various antipsychotic drugs, as well as AM-102 for the tinnitus treatment. The company has a collaboration and license agreement with INSERM; and Xigen S.A. to develop, manufacture, and commercialize pharmaceutical products, as well as drug delivery devices and formulations for local administration of therapeutic substances to the inner ear for the treatment of ear disorders. Auris Medical Holding Ltd. was founded in 1998 and is headquartered in Hamilton, Bermuda.